biOasis Technologies Ord Shs V.BTI

Primary Symbol: V.BTI.H Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > sent a pm to kbc this morning - no response

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Dec 21, 2022 5:48pm

112 Views

Post# 35185866

RE:RE:RE:RE:RE:RE:sent a pm to kbc this morning - no response

"What's the big opinion being expressed right now? Psssst. Check the stock prices for BTI and MTP. Now there's a great big opinion being expressed in the market!"

The price of the stock price represents the value of your consistent pumping over the last decade. That's what it was worth.

What's the fully diluted market cap of Biodexa during what has been the worst biotech market in history where 25% of the industry has been trading below cash in recent months? You once laughed at Putin who helped accelerate inflation sending oil to $125 and agricultual prices spiking as he tried to weaponize inflation against the West as part of his war. Putin's laughing at you now as you capitulate at $.05 as global central banks have put the brakes to address inflation. The worst biotech market in history.